Type_substrate Report for: Derivative of Rivastigmine

Rivastigmine (Exelon) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. Used also as building block for multitarget compounds
See also this moiety in type of inhibitors: Derivative of Rivastigmine

Substrate	Main targeted enzyme families	Type

CHEMBL1784957	ACHE	Carbamate \| Derivative of Rivastigmine \| Drug \| Pro-Drug

Idalopirdine-rivastigmine	BCHE	5-HT-receptor-ligand \| Carbamate \| Derivative of Rivastigmine \| Drug \| Multitarget \| Pro-Drug

Send your questions or comments to :Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.

For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

webmaster

Acknowledgements and disclaimer